Brazil to pay for removal of defective breast implants

January 12, 2012

The government said Thursday it would pay for surgery on Brazilian women to remove defective French-made and Dutch-made breast implants.

The National Agency for Sanitary Surveillance (ANVISA) said an estimated 12,500 Brazilian women had been fitted with French-made PIP implants and another 7,000 with Dutch-made Rofil implants.

"Patients with PIP or Rofil implants with rupture problems will be treated by the public (health) system, said ANVISA president Dirceu Barbano.

"The government understands that a ruptured implant implies reparatory surgery that can be done in the public system, like any reparatory surgery. If needed, the implant will be replaced," he added.

For those women who do not have problems with the implants, the government will provide periodic checkups, ANVISA said.

PIP, like Rofil which used the same material, was shut down and its products banned in April 2010 after it was revealed to have been using non-authorized, sub-standard that caused abnormally high implant rupture rates.

Brazil this week will start listing women who have had implants and identify the type of gel used but the move is not linked to PIP and was decided two years ago, according to Jose Horacio Aboudib, the head of Brazilian .

About 1,000 South American women plan to sue the French firm PIP over the potentially faulty the company supplied to about 300,000 women across the world, their lawyer said Tuesday.

Lawyer Arie Alimi said about 500 Argentinian and an equal number from Venezuela were planning to be civil plaintiffs in the probe by French police into PIP and its 72-year-old founder Jean-Claude Mas.

More than 450 lawsuits have been filed in three countries, and French police have placed PIP and Mas under investigation.

According to PIP's 2010 bankruptcy filing, it had exported 84 percent of its annual production of 100,000 implants.

Explore further: Dutch urge removal of faulty PIP breast implants

Related Stories

Dutch urge removal of faulty PIP breast implants

January 11, 2012
Dutch health authorities on Wednesday recommended the removal of breast implants made by now-defunct French company PIP after conflicting reports about the product's safety.

Brazil bans sale of Dutch co's breast implants

January 11, 2012
(AP) -- The sale of Dutch-branded breast implants made by a French company at the center of an international scandal has been banned in Latin America's biggest country, Brazil's health ministry said Wednesday.

Breast implant maker used non-approved gels: lawyer

December 27, 2011
The founder of the French firm that made breast implants feared to be at risk of rupturing has admitted using non-approved but non-toxic silicone gels, his lawyer said Tuesday.

Five women in Belgium have had PIP implants removed

January 9, 2012
Five women in Belgium have had potentially faulty breast implants made by French firm PIP removed since the beginning of December, the country's health watchdog said Saturday.

20 cancer cases in French women with PIP implants: agency

December 30, 2011
French health authorities said Friday that 20 cases of cancer had been uncovered in women with allegedly faulty French-made breast implants but insisted there was still no proven link with the disease.

Italy seeking women with French breast implants

December 22, 2011
(AP) -- Italy's health ministry on Thursday asked hospitals to track down women who received silicone breast implants made by a suspect French company due to concerns the implants may be unsafe.

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.